About Entopsis
Entopsis is a company based in Miami (United States) founded in 2011.. Entopsis has raised $1.05 million across 3 funding rounds from investors including Krillion Ventures, G3 Capital Partners and Breakout Ventures. Entopsis offers products and services including NuTec, OpsisDx, and PCRopsis Oral Rinse. Entopsis operates in a competitive market with competitors including Tethis, GNA Biosolutions, NanoVation-GS, AlphaSIP and Ellume, among others.
- Headquarter Miami, United States
-
Sectors
Technology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Entopsis Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.05 M (USD)
in 3 rounds
-
Latest Funding Round
$250 K (USD), Seed
Dec 14, 2016
-
Investors
Krillion Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Entopsis
Entopsis offers a comprehensive portfolio of products and services, including NuTec, OpsisDx, and PCRopsis Oral Rinse. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for unbiased molecular identification in health monitoring.
Platform for detecting and distinguishing multiple analytes in samples.
Tool for simple oral sample collection and transportation for testing.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Entopsis
Entopsis has successfully raised a total of $1.05M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $250,000
-
First Round
First Round
(01 May 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Seed - Entopsis | Valuation |
investors |
|
| Mar, 2015 | Amount | Seed - Entopsis | Valuation | Krillion Ventures | |
| May, 2012 | Amount | Grant - Entopsis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Entopsis
Entopsis has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Krillion Ventures, G3 Capital Partners and Breakout Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund based in Miami is operated.
|
Founded Year | Domain | Location | |
|
Limited information is provided about G3 Capital Partners.
|
Founded Year | Domain | Location | |
|
Early-stage science-driven companies are supported through venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Entopsis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Entopsis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Entopsis Comparisons
Competitors of Entopsis
Entopsis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tethis, GNA Biosolutions, NanoVation-GS, AlphaSIP and Ellume, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Automated solutions for liquid biopsy processing are provided.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for molecular pathogen detection are developed.
|
|
| domain | founded_year | HQ Location |
Nanomaterial-based sensors for respiratory monitoring devices are developed.
|
|
| domain | founded_year | HQ Location |
Nanotube-based biosensor chips are produced for real-time medical diagnostics.
|
|
| domain | founded_year | HQ Location |
Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Entopsis
Frequently Asked Questions about Entopsis
When was Entopsis founded?
Entopsis was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Entopsis located?
Entopsis is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Is Entopsis a funded company?
Entopsis is a funded company, having raised a total of $1.05M across 3 funding rounds to date. The company's 1st funding round was a Grant of $160K, raised on May 01, 2012.
What does Entopsis do?
Specialized glass slides known as NUTEC were developed by the company, founded in 2011 and based in Miami, United States, to enable detection of DNA, RNA, proteins, and small molecules through colorimetric changes. Software utilizing machine learning is provided for data analysis. Operations focus on diagnostics in oncology, autoimmune conditions, and rare diseases within the health technology sector.
Who are the top competitors of Entopsis?
Entopsis's top competitors include Tethis, GNA Biosolutions and NanoVation-GS.
What products or services does Entopsis offer?
Entopsis offers NuTec, OpsisDx, and PCRopsis Oral Rinse.
Who are Entopsis's investors?
Entopsis has 3 investors. Key investors include Krillion Ventures, G3 Capital Partners, and Breakout Ventures.